AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E401579-T1: [Translated] TRANSFER OF CALIBRATED TIME INFORMATION IN A MOBILE DEVICE

Chemical patent from PubChem database. Patent Number: AT-E401579-T1. Title: Novel Chemical Entity. Filing Date: 2004-04-24. Inventors: Martinez, Carlos, Thompson, Emily. Abstract: The invention relates to a novel chemical entity with unique structural features and biological properties, suitable for development as a therapeutic ... IPC Classifications: A61K, A61L, A61F. This patent covers 13 claims related to 6 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Treatment Episode Data Set: Admissions (TEDS-A-2006)

<p>The Treatment Episode Data Set -- Admissions (TEDS-A) is a national census data system of annual admissions to substance abuse treatment facilities. TEDS-A provides annual data on the number and characteristics of persons admitted to public and private substance abuse treatment programs that receive public funding. The unit of analysis is a treatment admission. TEDS consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.<br />
A sister data system, called the Treatment Episode Data Set -- Discharges (TEDS-D), collects data on discharges from substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.<br />
TEDS variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".<br />
Variables in the MDS include: information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008).<br />
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.<br />
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.This study has 1 Data Set.</p>
NSDUH 2020 Data Collection Final Report

This report describes data collection operations for the 2020 National Survey on Drug Use and Health (NSDUH). It details the sampling, counting, and listing operations; data collection staffing; preparation of survey materials; field staff training; data collection (both in-person and web); data collection results; and quality control practices. It also includes information on Coronavirus 2019 safety protocols and training materials.The document is available as a PDF.
Highly efficient genetic transduction of primary human synoviocytes with concentrated retroviral supernatant

We are developing retroviral-mediated gene transfer to human fibroblast-like synovial cells (FLS) as one approach to characterizing genetic pathways involved in synoviocyte pathophysiology. Prior work has suggested that FLS are relatively refractory to infection by Moloney murine leukemia virus based vectors. To determine if viral titer influenced the transduction efficiency of FLS, we optimized a rapid, efficient, and inexpensive centrifugation method to concentrate recombinant retroviral supernatant. The technique was evaluated by measurement of the expression of a viral enhanced green fluorescent protein transgene in transduced cells, and by analysis of viral RNA in retroviral supernatant. Concentration (100-fold) was achieved by centrifugation of viral supernatant for four hours, with 100% recovery of viral particles. The transduction of FLS increased from approximately 15% with unconcentrated supernatant, to nearly 50% using concentrated supernatant. This protocol will be useful for investigators with applications that require efficient, stable, high level transgene expression in primary FLS.
ROCKWOOL-Duke Global Child Welfare Database

The ROCKWOOL–Duke Global Child Welfare Database (RDGCWD) compiles cross-national aggregate information from the Global North about children who experienced contact with child welfare systems (CWS) or child protective services (CPS) between 2000 and 2020. Data were collected from national child welfare agencies or national or transnational statistical agencies, and include measures of child maltreatment investigations, confirmed child maltreatment, and children in out-of-home care. Population data are included for the measurement of incidence and prevalence of system contact. The RDGCWD provides a unique resource for comparative and longitudinal research on child maltreatment and child welfare systems. However, potential unobserved variation in the definition of child maltreatment or in the administration of child welfare and child protection warrant caution in the interpretation of variation and change in system contact.

Investigators: Alexander F. Roehrkasse, Ph.D.
Duke University
Liza Becker, B.A.
Duke University
Peter Fallesen, Ph.D.
Stockholm University
Christopher Wildeman, Ph.D.
Duke University
Compound 528634: Propanamide, N-isobutyl-2-methyl

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-N-(2-methylpropyl)propanamide. Molecular Formula: C8H17NO. Molecular Weight: 143.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Calcium dynamics during fertilization in

Background
          Of the animals typically used to study fertilization-induced calcium dynamics, none is as accessible to genetics and molecular biology as the model organism Caenorhabditis elegans. Motivated by the experimental possibilities inherent in using such a well-established model organism, we have characterized fertilization-induced calcium dynamics in C. elegans.
        
        
          Results
          Owing to the transparency of the nematode, we have been able to study the calcium signal in C. elegans fertilization in vivo by monitoring the fluorescence of calcium indicator dyes that we introduce into the cytosol of oocytes. In C. elegans, fertilization induces a single calcium transient that is initiated soon after oocyte entry into the spermatheca, the compartment that contains sperm. Therefore, it is likely that the calcium transient is initiated by contact with sperm. This calcium elevation spreads throughout the oocyte, and decays monotonically after which the cytosolic calcium concentration returns to that preceding fertilization. Only this single calcium transient is observed.
        
        
          Conclusion
          Development of a technique to study fertilization induced calcium transients opens several experimental possibilities, e.g., identification of the signaling events intervening sperm binding and calcium elevation, identifying the possible roles of the calcium elevation such as the completion of meiosis, the formation of the eggshell, and the establishing of the embryo's axis of symmetry.
Body mass indices in patients with disabling hip osteoarthritis

Hip osteoarthritis (OA) is a degenerative joint disease that results in substantial morbidity. The disease may be preventable in some instances by reducing risk factors associated with the disease. We undertook a study to determine whether being overweight or obese, a health risk that applies to younger and older age groups, is commonly associated with hip joint OA. The body mass indices (BMIs) of 1021 males and females ranging in age from 23 to 94 years and requiring surgery for end-stage hip joint OA were analyzed to find the prevalence of high body weights at the time of surgery. Being overweight was defined as having a BMI of 25–29.9 kg/m2 and being obese as having a BMI >30 kg/m2. BMIs indicative of overweight were recorded for 68% of the patients surveyed. Of 35 patients aged 30–39 years, 53.3% had BMIs >25, with a mean of 28.8, which nearly reaches the lower limit defined for obesity. On average, patients who had had previous surgery and complications warranting reimplantation of new surgical devices had BMIs in the obese range. Our findings suggest that a high percentage of patients with end-stage hip OA are overweight, including younger adults and those with symptoms of 3–6 months' duration. Moreover, patients whose BMIs are in the obese range may be at increased risk for removal and reimplantation of their prosthesis.
The SACWIS Assessment Review Report (SARR) Action Plan Development and Tracking

This webinar, sponsored by the Children's Bureau's Division of State Systems (DSS) builds on guidance set forth in Statewide Automated Child Welfare Information Systems (SACWIS) Technical Bulletin #1: Action Plan Guidance and Examples issued in December, 2005. This webinar provided direction on how to construct an action plan, identified common pitfalls and benefits of action plans and described the tracking process for action plans. The webinar included time for Q&A and audience discussion. Speakers included Joe Castro, consultant to the Children's Bureau, Pete Howe, Division of State Systems, Children's Bureau and Dian Carroll, Division of State Systems, Children's Bureau.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525188: Tripropylene glycol, diacetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-(2-acetyloxypropoxy)propoxy]propyl acetate. Molecular Formula: C13H24O6. Molecular Weight: 276.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399768-T1: [Translated] INDAZOL DERIVATIVES AND THEIR USE AS CRF ANTAGONISTS

Chemical patent from PubChem database. Patent Number: AT-E399768-T1. Title: Chemical Synthesis Method. Filing Date: 1996-06-27. Inventors: Chen, Wei, Kumar, Raj, Williams, Sarah. Abstract: A novel method for chemical synthesis is provided, utilizing specific catalysts and reaction conditions to achieve selective transformations with high... IPC Classifications: C07D, C07F, A61K. This patent covers 14 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Patent AT-E40114-T1: [Translated] MICROBICIDES SULFENYL PYRROLES.

1. Claims for Contracting States BE, CH, DE, FR, GB, IT, LI, NL Compounds of the general formula I  see diagramm : EP0096142,P25,F1 wherein R1 is a fragment [X, Y, Z(phenyl)], [X, Y, Z(biphenyl)], [U, V, W(pyridyl)], [U, V, W(furyl)] or [U, V, W(thienyl)], wherein X, Y and Z are each independently hydrogen, halogen, C1 -C4 alkyl, C1 -C3 haloalkyl, di(C1 -C4 alkyl)amino, nitro, cyano, -COO(C1 -C4 alkyl), -CON(C1 -C4 alkyl)2 or the group -E-R4 , wherein E is -O-, -S-, -SO- or -SO2 -, R4 is C1 -C6 alkyl which is unsubstituted or substituted by C1 -C4 alkoxy, unsubstituted C3 -C5 alkenyl, C3 -C5 alkynyl which is unsubstituted or substituted by halogen or hydroxy, or is [X, Y, Z(phenyl)] or -CH2 -[X, Y, Z-(phenyl)] ; U, V and W are each independently hydrogen, halogen or C1 -C4 alkyl ; R2 is -COO(C1 -C6 alkyl), -CO-(C1 -C6 alkyl), -CO-N(C1 -C6 alkyl)2 , cyano, nitro, -SO2 -(C1 -C6 alkyl), -P(O)-(C1 -C6 alkoxy)2 or -SO2 -N(C1 -C6 alkyl)2 ; and R3 is C1 -C3 haloalkyl. 1. Claims for Contracting State AT A microbicidal composition for controlling or preventing an attack on living plants and/or for preserving perishable storable goods of vegetable or animal origin, which composition contains, as at least one active component, one of the compounds of the general formula I see diagramm : EP0096142,P27,F1  wherein R1 is a fragment [X, Y, Z(phenyl)], [X, Y, Z(biphenyl)], [U, V, W(pyridyl)], [U, V, W(furyl)] or [U, V, W(thienyl)], wherein X, Y and Z are each independently hydrogen, halogen, C1 -C4 alkyl, C1 -C3 haloalkyl, di(C1 -C4 alkyl)amino, nitro, cyano, -COO(C1 -C4 alkyl), -CON(C1 -C4 alkyl)2 or the group -E-R4 , wherein E is -O-, -S-, -SO- or -SO2 -, R4 is unsubstituted C1 -C6 alkyl, C3 -C5 alkenyl which is unsubstituted or substituted by halogen, C3 -C5 alkynyl which is unsubstituted or substituted by halogen or hydroxy, or is [X, Y, Z(phenyl)] or -CH2 -[X, Y, Z(phenyl)] ; U, V and W are each independently hydrogen, halogen or C1 -C4 alkyl ; R2 is -COO(C1 -C6 alkyl), -CO-(C1 -C6 alkyl), -CO-N(C1 -C6 alkyl)2 , cyano, nitro, -SO2 -(C1 -C6 alkyl), -P(O)-(C1 -C6 alkoxy)2 or -SO2 -N(C1 -C6 alkyl)2 ; and R3 is C1 -C3 haloalkyl.
The NSDUH Report: Accessing National and State Data from the National Survey on Drug Use and Health

This short report summarizes the type of national-, State-, and substate-level publications and methodologies using National Survey on Drug Use and Health (NSDUH). Information on accessing the NSDUH public-use file (PUF), the restricted-use data analysis system (R-DAS), and other future NSDUH data access options are discussed.
Patent AT-E400644-T1: [Translated] TRANSGENIC ORGANISMS WITH LOWER GROWTH TEMPERATURE

The invention relates to the growth temperature of organisms, especially plants and microorganisms and the manipulation of the tolerable cultivation temperature. More specifically, the present invention relates to the expression of heterologous proteins in microorganisms, and especially to the heterologous expression of heat sensitive proteins in bacteria, either gram-negative or gram-positive. In a first aspect, the present invention provides a method for manipulation of cells and the resultant cells, wherein at least one gene from a psychrophilic micro organism coding for at least one chaperone or chaperonin is expressed. Such cells are selected among cultivated eukaryotic cells, i.e. animal and plant cells and entire plants, gram-negative and gram-positive bacteria, fungi and yeasts.
DQS Initial injury-related visits to hospital emergency departments, by sex, age, and intent and mechanism of injury: United States (Archived)

This topic is no longer available in the NCHS Data Query System (DQS). Data on initial injury-related visits to hospital emergency departments in the United States, by sex, age, and intent and mechanism of injury. Data are from Health, United States. SOURCE: National Center for Health Statistics, National Hospital Ambulatory Medical Care Survey.
Search, visualize, and download these and other estimates from over 150 health topics with the NCHS Data Query System (DQS), available from: https://www.cdc.gov/nchs/dataquery/index.htm.
Compound 528359: 1,2,4,6-Tetrathiepane, 3,5,7-trimethyl-

Chemical compound data from PubChem database. IUPAC Name: 3,5,7-trimethyl-1,2,4,6-tetrathiepane. Molecular Formula: C6H12S4. Molecular Weight: 212.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NSDUH 2022 Sample Experience Report

This report is a follow-up to the 2022 National Survey on Drug Use and Health (NSDUH)Sample Design Report. It further documents the 2022 NSDUH sample experiences by comparing expected outcomes with what actually occurred, and documenting unexpected issues that came up during the year. A summary of the sample design is included for context.Chapters:Introduces the report and summarizes the impact of the coronavirus 2019 (COVID-19) pandemic on sample design and data collection.Revisits the 2022 sample design.Documents the sample experiences at the segment levelDocuments the sample experiences at the dwelling-unit levelDocuments the sample experiences at the person levelLooks at sampling error, through a computation of design effects and a comparison of observed and expected precision
New York State Statewide COVID-19 Fatalities by Sex (Archived)

<b>Note:</b> Data elements were retired from HERDS on 10/6/23 and this dataset was archived.

This dataset includes the cumulative number and percent of healthcare facility-reported fatalities for patients with lab-confirmed COVID-19 disease by reporting date and patient sex.  This dataset does not include fatalities related to COVID-19 disease that did not occur at a hospital, nursing home, or adult care facility. The primary goal of publishing this dataset is to provide users with information about healthcare facility fatalities among patients with lab-confirmed COVID-19 disease. 

The information in this dataset is also updated daily on the NYS COVID-19 Tracker at https://www.ny.gov/covid-19tracker.

The data source for this dataset is the daily COVID-19 survey through the New York State Department of Health (NYSDOH) Health Electronic Response Data System (HERDS). Hospitals, nursing homes, and adult care facilities are required to complete this survey daily. The information from the survey is used for statewide surveillance, planning, resource allocation, and emergency response activities. Hospitals began reporting for the HERDS COVID-19 survey in March 2020, while Nursing Homes and Adult Care Facilities began reporting in April 2020. It is important to note that fatalities related to COVID-19 disease that occurred prior to the first publication dates are also included. 

The fatality numbers in this dataset are calculated by summing the patient fatalities by patient sex, as of each reporting date. The statewide total fatality numbers are calculated by summing the number of fatalities across all patient sexes, by reporting date. The fatality percentages are calculated by dividing the number of fatalities in each patient sex by the statewide total number of fatalities, by reporting date. The fatality numbers represent the cumulative number of fatalities that have been reported as of each reporting date.
Denver: Drug-Related Emergency Department Visits, 2004-2011 - Suicide Attempts

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving suicide attempts in the Denver metropolitan area, covering 2004-2011.  Drug-related suicide attempts include visits for drug overdoses and for suicide attempts by other means (e.g., using a firearm) if drugs were involved or related to the suicide attempt.
Compound 528090: ethyl N-(4-methylphenyl)carbamate

Chemical compound data from PubChem database. IUPAC Name: ethyl N-(4-methylphenyl)carbamate. Molecular Formula: C10H13NO2. Molecular Weight: 179.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Publications Using SAMHSA DataBehavioral Health Barometer: Louisiana, 2014

This is a behavioral health report for the state of Louisiana. It uses the National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment Services (NSSATS) to address the topics of youth substance use, youth mental health and treatment, adult mental health and treatment, substance use, and substance use treatment for the years 2009 to 2013.
Compound 528253: 2-Methyl-5-pentylthiophene

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-5-pentylthiophene. Molecular Formula: C10H16S. Molecular Weight: 168.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Child Welfare Information Study (NCWIS)

How we access information and use technology is rapidly changing. With so many ways to access an ever increasing amount of information, it is becoming increasingly difficult for information clearinghouses and technical assistance providers to be responsive to the needs and preferences of a diverse child welfare workforce and to get useful, trusted information into the hands of those who need it most. The Child Welfare Information Gateway, funded by the Children's Bureau, conducted a research study to better understand how professionals search for, access, and share information, including their use of social media and technology. The study gathered data about the behaviors and preferences of current and future members of the child welfare workforce, including child welfare agency professionals, child welfare professionals working with Tribes, legal professionals, and students in social work programs through an online survey, tailored to each respondent group, and telephone focus groups. To ensure the study design and instruments were informed by appropriate stakeholders, various experts were engaged through stakeholder groups to provide structured feedback on overall study design, target audiences, and instrument development. Stakeholder groups were composed of experts in child welfare systems, issues, policies, technology, communication, and research methodology. Study participants were invited to be a part of the study through a variety of channels, including the agencies for which they worked, through intermediary organizations such as professional associations, and through contacts at university social work programs. Because of the different contexts of each of the targeted audiences, recruitment approaches were tailored and multiple methods were used to maximize responses. Ultimately, 4,134 individuals responded to the survey, including 3,191 child welfare agency professionals, 122 child welfare professionals working with Tribes, 371 legal professionals, and 450 students in social work programs. Study findings are meant to support the enhanced design and reach of information, resources, and services for child welfare agency administrators, program managers, supervisors, caseworkers, judges and attorneys, and future members of the child welfare workforce so that they are more accessible, useful, and effective for improving child welfare practice.

Investigators: Brian Deakins, U.S. Department of Health and Human Services, Administration for Children and Families, Children's Bureau
Christine Leicht, Child Welfare Information Gateway
Michael Long, Child Welfare Information Gateway
Sharika Bhattacharya, Child Welfare Information Gateway
Elizabeth Eaton, Child Welfare Information Gateway
Dannele Ferreras, Child Welfare Information Gateway
Katelyn Sedelmyer, Child Welfare Information Gateway
Sarah Pfund, Child Welfare Information Gateway
Christina Zdawczyk, Child Welfare Information Gateway